Amy Wehn

Biography

  Amy Wehn received her Ph.D. from the University of Pittsburgh in Molecular Biology. She then completed a post-doctoral fellowship at the University of North Carolina Lineberger Comprehensive Cancer Center, utilizing genome-wide screening to uncover biomarkers and drug targets for rational combinatorial chemotherapeutic design. Amy then moved into industry where she has held various client-facing, consultative positions of increasing responsiblity in the immuno-oncology and cell-therapy fields. In her current role at HTG Molecular, Amy directly manages projects that use HTG's  targeted RNA sequencing technology in clinical trials and companion diagnostic programs; liaising between Laboratory Operations, Sales, Marketing, and the customer.

Research Interest

 Immuno-oncology